Oligoprogression and Osimertinib Continuation Post-progression in Patients with EGFR-Mutations
JOURNAL OF THORACIC ONCOLOGY(2024)
Key words
Osimertinib,Non-small cell lung cancer,Metastatic
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined